At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after ...

Thanks to in-utero blood transfusion technology, what was once a fatal diagnosis in the womb can now result in live births.

The global cell and gene therapy market is experiencing significant expansion, driven by rising approvals and advancements in ...

Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of ...

The drug, Yescarta, is reportedly sold in Singapore for about S$480,700. Read more at straitstimes.com. Read more at ...

Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new ...

If you’ve been following Prime Medicine (PRME) lately, you probably noticed the recent buzz surrounding its presentation at the Cell & Gene Therapy International 2025 conference in Boston. The ...

Construction has begun on a new centre for gene and cell therapy in the German capital, Berlin. The "Translation Centre" will ...

NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...